Authors: Braybrooke, JP Vallis, KA Houlbrook, S Rockett, H Ellmen, J Anttila, M Ganesan, TS Harris, AL Talbot, DC

Citation: Jp. Braybrooke et al., Evaluation of toremifene for reversal of multidrug resistance in renal cell cancer patients treated with vinblastine, CANC CHEMOT, 46(1), 2000, pp. 27-34

Authors: Braybrooke, JP Houlbrook, S Crawley, JE Propper, DJ O'Byrne, KJ Stratford, IJ Harris, AL Shuker, DEG Talbot, DC

Citation: Jp. Braybrooke et al., Evaluation of the alkaline comet assay and urinary 3-methyladenine excretion for monitoring DNA damage in melanoma patients treated with dacarbazine and tamoxifen, CANC CHEMOT, 45(2), 2000, pp. 111-119

Authors: Blancher, C Moore, JW Talks, KL Houlbrook, S Harris, AL

Citation: C. Blancher et al., Relationship of hypoxia-inducible factor (HIF)-1 alpha and HIF-2 alpha expression to vascular endothelial growth factor induction and hypoxia survival in human breast cancer cell lines, CANCER RES, 60(24), 2000, pp. 7106-7113

Authors: Braybrooke, JP Propper, DJ O'Byrne, KJ Koukourakis, MI Patterson, AV Houlbrook, S Love, SD Varcoe, S Taylor, M Ganesan, TS Talbot, DC Harris, AL

Citation: Jp. Braybrooke et al., Induction of thymidine phosphorylase as a pharmacodynamic end-point in patients with advanced carcinoma treated with 5-fluorouracil, folinic acid andinterferon alpha, BR J CANC, 83(2), 2000, pp. 219-224

Authors: Moody, CJ Roffey, JRA Swann, E Lockyer, S Houlbrook, S Stratford, IJ

Citation: Cj. Moody et al., Synthesis and cytotoxic activity of thiazolyl indolequinones, ANTI-CANC D, 10(6), 1999, pp. 577-589

Authors: Chao, D Bahl, P Houlbrook, S Hoy, L Harris, AL Austyn, JM

Citation: D. Chao et al., Human cultured dendritic cells show differential sensitivity to chemotherapy agents as assessed by the MTS assay, BR J CANC, 81(8), 1999, pp. 1280-1284